“In Silico Investigation of DLBS3233 Bioactives Targeting Inflammatory, Metabolic, and Cholesterol Transport Pathways in Gallstone (Cholelithiasis) Pathogenesis”, Nutr Clín Diet Hosp, vol. 46, no. 1, Feb. 2026, doi: 10.12873/461baulia.